- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 13, 2025 | 32.2M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 32.2M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 31.24M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 758.97K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 758.97K sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$19.21M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$8.13M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $17.4M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $10.42M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $28.42M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $22.69M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $29.98M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $23.76M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | −$10.83M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | −$5.29M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | −$5.52M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $7.22M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $2.55M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $10.32M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $5.5M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $30.81M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $29.25M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $33.01M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $29.25M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.25 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.69 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$7.30 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$11.54 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.25 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.69 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$7.30 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$11.54 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.02M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $3.42M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $616.09K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $836.66K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $7.01M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $18.79M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $4M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $7M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$7.96M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$21.49M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$5.54M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$8.76M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$8.03M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$22.21M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$4.62M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$7.84M |